Henry I. Miller - Publications, H-index & Citations

Henry I. Miller

university of nottingham

19H指数

339论文数

1.7K被引数

收录论文 64

发表时间

Full Clinical Pathological and Bacteriological Investigation of a Giant Nasal Polyp Associated With the Developing Apex of the Permanent Fourth Premolar (Triadan 108) in a 3-year-old Connemara Filly: A Case Report 一例3岁康纳马拉母驹巨大鼻息肉与恒第四前磨牙（Triadan 108）发育尖相关的临床病理学和细菌学全面检查：病例报告

Veterinary Medicine and Science

IF1.7

2025-12-28

OAAI

Sidwell, Amelia; Shanklin, Alexander; Miller, Henry; Cahoon, Molly; Hole, Sam Luis; Bianco, Carlo; Pereira, Regina

Will the Biden administration 'follow the science' on regulatory reform?

NATURE BIOTECHNOLOGY

IF41.7

2021-10-01

PREAI

Cohrssen, John J.; Miller, Henry I.

US Congress mandates silliness, USDA complies

NATURE BIOTECHNOLOGY

IF41.7

2019-05-03

PREAI

Miller, Henry I.; Kershen, Drew L.

A Plea for the Renewal of the ISBR

TRENDS IN BIOTECHNOLOGY

IF14.9

2018-03-01

PREAI

Tagliabue, Giovanni; Kuntz, Marcel; Miller, Henry I.; Ammann, Klaus

FDA is the wrong agency to regulate genetically engineered animals

NATURE BIOTECHNOLOGY

IF41.7

2017-07-01

OAAI

Cohrssen, John J.; Miller, Henry I.

US National Academies report misses the mark

NATURE BIOTECHNOLOGY

IF41.7

2016-12-07

PREAI

Giddings, L. Val; Miller, Henry

A risk-based approach to the regulation of genetically engineered organisms

NATURE BIOTECHNOLOGY

IF41.7

2016-05-06

PREAI

Conko, Gregory; Kershen, Drew L.; Miller, Henry; Parrott, Wayne A.

Recasting Asilomar's lessons for human germline editing

NATURE BIOTECHNOLOGY

IF41.7

2015-11-06

PREAI

Miller, Henry I.

What's behind a 'genetically engineered' label?

NATURE BIOTECHNOLOGY

IF41.7

2015-05-12

PREAI

Brookes, Graham; Miller, Henry I.

Basic research is often best appreciated in retrospect

NATURE BIOTECHNOLOGY

IF41.7

2014-01-09

PREAI

Miller, Henry I.

Comment on Long term toxicity of a Roundup herbicide and a Roundup-tolerant genetically modified maize by Seralini et al.

FOOD AND CHEMICAL TOXICOLOGY

IF3.5

2013-03-01

OAAI

Wager, Robert; Lerayer, Alda; Fedoroff, Nina; Giddings, L. Val; Strauss, Steven H.; Leaver, Chris; Shantharam, Sivramiah; Potrykus, Ingo; Fellous, Marc; Burachik, Moises; Jany, Klaus-Dieter; Trewavas, Anthony; Rao, C. Kameswara; Prakash, C. S.; Miller, Henry I.; Wesson, Robert; Bradford, Kent; Cetiner, Selim; McHughen, Alan; De Stefano-Beltran, Luis; Chassy, Bruce M.; AlMomin, Sabah; Newell-McGloughlin, Martina; Ammann, Klaus; Herring, Ronald J.; de Souza, Lucia; Perill, Elizabeth

A label we don't need

NATURE BIOTECHNOLOGY

IF41.7

2011-11-08

PREAI

Miller, Henry I.; Kershen, Drew L.

Why an abbreviated FDA pathway for biosimilars is overhyped

NATURE BIOTECHNOLOGY

IF41.7

2011-09-08

OAAI

Miller, Henry I.